U.S. Senators Ask Gilead to Explain $84,000 Hep C Drug Pricing
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc)
People Charles Grassley (United States Senate) Ronald Wyden (United States Senate) Amy Flood (Gilead Sciences Inc) John Martin (Gilead Sciences Inc)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283